|
業務類別
|
Biotechnology |
|
業務概覽
|
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science. |
| 公司地址
| 103 Carnegie Center Drive, Suite 300, Princeton, NJ, USA, 08852 |
| 電話號碼
| +1 609 495-2200 |
| 傳真號碼
| +1 609 495-2202 |
| 公司網頁
| https://www.palatin.com |
| 員工數量
| 29 |
| Mr. Stephen Thomas Wills, C.P.A. |
Chief Financial Officer, Principal Accounting Officer, Chief Operating Officer, Executive Vice President, Secretary and Treasurer |
美元 670.00K |
25/06/2026 |
| Dr. Carl Spana,PhD |
Chief Executive Officer, President and Director |
美元 721.00K |
25/06/2026 |
|
|
| Ms. Arlene M. Morris |
Independent Director |
25/06/2026 |
| Dr. Alan W. Dunton,M.D. |
Independent Director |
25/06/2026 |
| Dr. Carl Spana,PhD |
Chief Executive Officer, President and Director |
25/06/2026 |
| Dr. John K.A. Prendergast,PhD |
Non-Executive Chairman of the Board |
25/06/2026 |
|
|
|
|
